Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
64Cu-GRIP B PET Imaging in Acute Myocarditis
NCT07481136Phase 1Not yet recruiting
- Start
- Jan 2027
- Primary completion
- Nov 2030
- Modality
- Peptide-Drug Conjugates
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of 64Cu-GRIP B in acute myocarditis. Primary endpoints: Feasibility of detecting affected cardiac tissue at Day 70 and Number of areas of cardiac inflammation detected at Day 70. Planned start Jan 2027; status: not yet recruiting.
02
Drugs
64Cu-GRIP B
03
Conditions
acute myocarditis
Beyond the preview
Go deeper on NCT07481136.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07481136.